Behavioral Pharma (United States)
In research, Behavioral Pharma (United States) stands highest in Health Sciences (#7,696 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Neuroscience — Neuroscience is 10.5× its share of world research.
- World rank, 2022–2025
- #7,304 of 28,054 · #3,520 all time
- Rank in United States
- #970 of 4,192
- Research works
- 1.3k ▲ 17% vs 2013–17
- Citations
- 72k 54.4 per fractional work
- Top-10% rate
- 27.0% record average 16.5%
- Open access
- 35% world 28%
What is Behavioral Pharma (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #7,696 of 11,982 | 26.7% | 64 | #3806 |
Each strip is that field’s whole ranked pool, with the notch where Behavioral Pharma (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Behavioral Pharma (United States) specialise in?
Where its research is concentrated relative to its size: Neuroscience takes 10.5× the share of its output that it takes of world research.
- NeuroscienceField · 27.4 works10×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 10.5×. Every wedge is a field page.
- Neuroscience 10.5×
- Pharmacology, Toxicology and Pharmaceutics 9.3×
- Psychology 7.2×
- Veterinary 2.1×
- Medicine 1.9×
- Nursing 1.6×
- Health Professions 1.1×
- Biochemistry, Genetics and Molecular Biology 1.1×
- Immunology and Microbiology 0.7×
- Chemistry 0.7×
- Decision Sciences 0.5×
- Dentistry 0.5×
- Mathematics 0.4×
- Social Sciences 0.3×
- Computer Science 0.2×
- Environmental Science 0.2×
- Agricultural and Biological Sciences 0.1×
- Business, Management and Accounting 0.1×
- Economics, Econometrics and Finance 0.1×
- Materials Science 0.1×
- Chemical Engineering 0.1×
- Arts and Humanities 0.1×
- Physics and Astronomy 0.0×
- Engineering 0.0×
Which keywords describe research at Behavioral Pharma (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Depression, Epidemiology, Neurological Disorders, Anxiety, Neurobiology, Serotonin, Substance Use Disorders and Psychiatric Disorders.
- Insomnia
- Cognitive Impairment
- Psychometric Evaluation
- Therapeutic
- Psilocybin
- Dopamine
- Genetic Variation
- Mortality Risk
- Global Burden of Disease
- Neural Plasticity
- Cannabinoid Receptors
- Prevalence
- Metabolic Disorders
- Neuroprotection
- Meta-Analysis
- Behavioral Interventions
- Treatment
- Serotonin
- Anxiety
- Depression
- Epidemiology
- Neurological Disorders
- Neurobiology
- Substance Use Disorders
- Psychiatric Disorders
- Genetics
- Stress
- Health Consequences
- Prefrontal Cortex
- Circadian Rhythms
- Endocannabinoid System
- Impulsivity
- Alcohol Dependence
- Motivational Interviewing
- Adolescents
- Reward Circuitry
- Psychedelics
- Cognitive Behavioral Therapy
- Emotion Regulation
- Neuroimaging
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology18▲ 2.9×41 topics
- Depression16▲ 11×18 topics
- Neurological Disorders11▲ 12×14 topics
- Anxiety10▲ 14×10 topics
- Neurobiology10▲ 24×9 topics
- Serotonin10▲ 157×2 topics
- Substance Use Disorders9▲ 76×2 topics
- Treatment9▲ 4.6×10 topics
- Psychiatric Disorders8▲ 39×4 topics
- Behavioral Interventions8▲ 60×2 topics
- Genetics8▲ 6.7×9 topics
- Meta-Analysis7▲ 7.7×8 topics
- Stress7▲ 12×7 topics
- Neuroprotection7▲ 12×5 topics
- Health Consequences6▲ 14×3 topics
- Metabolic Disorders6▲ 33×3 topics
- Prefrontal Cortex6▲ 49×3 topics
- Prevalence6▲ 9.6×10 topics
- Circadian Rhythms6▲ 38×2 topics
- Cannabinoid Receptors6▲ 115×1 topic
- Endocannabinoid System6▲ 115×1 topic
- Neural Plasticity6▲ 21×4 topics
- Impulsivity6▲ 69×2 topics
- Global Burden of Disease6▲ 14×3 topics
- Alcohol Dependence6▲ 85×1 topic
- Mortality Risk6▲ 14×5 topics
- Motivational Interviewing6▲ 85×1 topic
- Genetic Variation5▲ 16×4 topics
- Adolescents5▲ 8.7×7 topics
- Dopamine5▲ 135×1 topic
- Reward Circuitry5▲ 135×1 topic
- Psilocybin5▲ 189×1 topic
- Psychedelics5▲ 189×1 topic
- Therapeutic5▲ 32×2 topics
- Cognitive Behavioral Therapy5▲ 22×2 topics
- Psychometric Evaluation4▲ 31×2 topics
- Emotion Regulation4▲ 8.5×6 topics
- Cognitive Impairment4▲ 10×7 topics
- Neuroimaging4▲ 9.7×10 topics
- Insomnia4▲ 38×2 topics
Which research topics does Behavioral Pharma (United States) publish most on?
By volume in 2022–2025: Cannabis and Cannabinoid Research, Substance Abuse Treatment and Outcomes, Neurotransmitter Receptor Influence on Behavior and Psychedelics and Drug Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cannabis and Cannabinoid Research Pharmacology 6 works
- 2 Substance Abuse Treatment and Outcomes Epidemiology 6 works
- 3 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 5 works
- 4 Psychedelics and Drug Studies Clinical Psychology 5 works
- 5 Forensic Toxicology and Drug Analysis Toxicology 4 works
- 6 Sleep and related disorders Experimental and Cognitive Psychology 4 works
- 7 Opioid Use Disorder Treatment Public Health, Environmental and Occupational Health 4 works
- 8 Smoking Behavior and Cessation Physiology 2 works
- 9 Sleep and Wakefulness Research Cognitive Neuroscience 2 works
- 10 Behavioral and Psychological Studies Developmental and Educational Psychology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Behavioral Pharma (United States)'s research output changed?
Output in 2018–2022 was 17% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in La Jolla
- Scripps Institution of Oceanography
- Salk Institute for Biological Studies
- Scripps Clinic
- Sanford Burnham Prebys Medical Discovery Institute
- National University
- Neurosciences Institute
- La Jolla Alcohol Research
- NOAA National Marine Fisheries Service Southwest Fisheries Science Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.